(3) That mice treated therapeutically with the PPARγ agonist, PGZ, are protected from lethal PR8 infection, and conversely, that the PPARγcKO mice are more susceptible, indicates that PPARγ activation is critical for M2 macrophage-mediated resistance to PR8 infection. This evidence concerns the gene PPARG and infection.